banner
Bcr-Abl inhibitor Vodobatinib, Purity ≥98%
Inquiry

Cat. No.: X24-06-ZQ536

Bcr-Abl inhibitor Vodobatinib, Purity ≥98%

Synonym: 1388803-90-4; Vodobatinib, Purity ≥98%; Vodobatinib; K-0706; K0706; K0706

  • CAS Number: 1388803-90-4
  • Compound CID: 89884852
img
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Vodobatinib It targets .
Molecular Weight
453.926
Molecular Formula
C27H20ClN3O2
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Vodobatinib is researched as a novel kinase inhibitor for its effects on Bcr-Abl and other kinases in treating leukemia.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0